The effect of viruses on the ability to present antigens via the major histocompatibility complex

Microbes and Infection

Volumn 1, Issue 4, 1999, Pages 335-345

  Peters, Vicki B ^a   Sperber, Kirk E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation; Major histocompatibility complex; Viral pathogenesis

Indexed keywords

GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADENOVIRUS; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CYTOMEGALOVIRUS; HERPES VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEASLES VIRUS; NATURAL KILLER CELL; PAPILLOMA VIRUS; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS;

ADENOVIRIDAE; CYTOMEGALOVIRUS; HERPES; HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MEASLES VIRUS; PAPILLOMAVIRUS;

EID: 0032695539     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80029-X     Document Type: Review

References (63)

1. Ojcius D.M., Delarbre C., Kourilsky P., Gachelin G. Major histocompatibility complex class I molecules and resistance against intracellular pathogens. Crit. Rev. Immunol. 14:1994;193-220.
2. Pamer E.G., Sijts A.J., Villanueva M.S., Busch D.H., Vijh S. MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses. Immunol. Rev. 158:1997;129-136.
3. Hiltbold E.M., Ziegler H.K. Mechanisms of processing and presentation of the antigens of Listeria monocytogenes. Infect. Agent. Dis. 2:1994;314-323.
4. Harding C.V., Geuze H.J. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J. Cell. Biol. 119:1992;531-542.
5. Bouwer H.G., Barry R.A., Hinrichs D.J. Acquired immunity to an intracellular pathogen: Immunologic recognition of L. monocytogenes-infected cells. Immunol. Rev. 158:1997;137-146.
6. Garg N., Nunes M.P., Tarleton R.L. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing presentation pathway. J. Immunol. 158:1997;3293-3302.
7. +CTL. J. Immunol. 160:1998;1817-1823.
8. Louie M.J., Cuna W.R., Rodriquez D.E., Cuna C., Mayer L., Sperber K. Impairment of monocytic function during Trypanosoma cruzi infection. Clin. Diagn. Lab. Immunol. 1:1994;707-713.
9. Garcia M.R., Graham S., Harris R.A., Beverley S.M., Kaye P.M. Epitope cleavage by Leishmania endopeptidase (s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation. Eur. J. Immunol. 27:1997;1005-1013.
10. Flohe S., Lang T., Moll H. Synthesis stability and subcellular distribution of major histocompatibility complex II molecules in Langerhans cell infected with Leishmania major. Infect. Immun. 65:1997;3444-3450.
11. Doolan D.L., Wizel B., Hoffman S.L. Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs. Immunol. Res. 15:1996;280-305.
12. Riley E.M. The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens. Parasitology. 112:1996;S 39-51.
13. + T cells and the recognition of MHC class I molecules. Immunology. 89:1996;405-412.
14. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and Molecular Immunology. 1994;W.B. Saunders, Philadelphia, Pennsylvania.
15. Jones E.Y. MHC class I and class II structures. Curr. Opin. Immunol. 9:1997;75-79.
16. Cresswell P. Assembly transport and function of MHC class II molecules. Ann. Rev. Immunol. 12:1994;259-293.
17. Ojcius D.M., Gapin L., Kanellopoulos J.M., Kourilsky P. Is antigen processing guided by major histocompatiblity complex molecules? FASEB J. 8:1994;974-978.
18. Boss J.M. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:1997;107-113.
19. Cresswell P., Howard J.C. Antigen recognition. Curr. Opin. Immunol. 9:1997;71-74.
20. Koopmann J.O., Hämmerling G.J., Momburg F. Generation intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 9:1997;80-88.
21. Cresswell P. Invariant chain structure and MHC class II function. Cell. 84:1996;505-507.
22. Pieters J. MHC class II restricted antigen presentation. Curr. Opin. Immunol. 9:1997;89-96.
23. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell. 82:1995;155-165.
24. Lanier L.L. Natural killer cell receptors and MHC class I interactions. Curr. Opin. Immunol. 9:1997;126-131.
25. Hengel H., Koszinowski U.H. Interference with antigen processing by viruses. Curr. Opin. Immunol. 9:1997;470-476.
26. Oldstone M.B. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology. 234:1997;179-185.
27. Hill A.B. Mechanism of interference with the MHC class I-restricted pathway of antigen presentation by herpesviruses. Immunol. Cell Biol. 74:1996;523-526.
28. Gilbert M.J., Riddell S.R., Plachter B., Greenberg P.D. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature. 24:1996;720-722.
29. Wiertz E., Hill A., Tortorella D., Ploegh H. Cytomegaloviruses use multiple mechanisms to elude the host immune response. Immunol. Lett. 57:1997;213-216.
30. Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman W.J., Sedmak D.D. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. M. 187:1998;675-683.
31. + T lymphocytes. Cell. 77:1994;525-535.
32. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-415.
33. Fruh K., Ahn K., Djaballah H., Sempé P., VanEndert P.M., Tampé R., Peterson P.A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature. 375:1995;415-418.
34. Neumann L., Kraas W., Uebel S., Jung G., Tampé R. The active domain of the herpes simplex virus protein ICP47: a potent inhibitor of the transporter associated with antigen processing (TAP). J. Mol. Biol. 272:1997;484-492.
35. Beinert D., Neumann L., Uebel S., Tampé R. Structure of the viral TAP-inhibitor ICP47 induced by membrane association. Biochemistry. 36:1997;4694-4700.
36. Beier D.C., Cox J.H., Vining D.R., Cresswell P., Engelhard V.H. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152:1994;3862-3872.
37. Harrer T., Harrer E., Kalams S.A., Barbosa P., Trocha A., Johnson R.P., Elbeik T., Feinberg M.B., Buchbinder S.P., Walker B.D. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156:1996;2616-2623.
38. Rinaldo C., Huang X.L., Fan Z., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M., Gupta P. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors. J. Virol. 69:1995;5838-5842.
39. Clerici M., Giorgi J.V., Chou C.C., Gudeman V.K., Zack J.A., Gupta P., Ho H.N., Nishanian P.G., Berzofsky J.A., Shearer G.M. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1992;1012-1019.
40. Langlade-Demoyen P., Ngo-Giang-Huong N., Ferchal F., Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1994;1293-1297.
41. Pinto L.A., Sullivan J., Berzofsky J.A., Clerici M., Kessler H.A., Landay A.L., Shearer G.M. Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:1995;867-876.
42. Beretta A., Weiss S.H., Rappocciolo G., Mayur R., DeSantis C., Quirinale J., Cosma A., Robbioni P., Shearer G.M., Berzofsky J.A., Villa M.L., Siccardi A.G., Clerici M. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. J. Infect. Dis. 173:1996;472-476.
43. Harrer T., Harrer E., Kalams S.A., Elbeik T., Staprans S.I., Feinberg M.B., Cao Y., Ho D.D., Yilma T., Caliendo A.M., Johnson R.P., Buchbinder S.P., Walker B.D. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retro. 12:1996;585-592.
44. Lubaki N.M., Ray S.C., Dhruva B., Quinn T.C., Siliciano R.F., Bollinger R.C. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression. J. Infect. Dis. 175:1997;1360-1367.
45. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:1994;4650-4655.
46. Kerkau T., Schmitt-Landgraf R., Schimpl A., Wecker E. Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res. Hum. Retro. 5:1989;613-620.
47. Kerkau T., Gernert S., Kneitz C., Schimpl A. Mechanism of MHC class I downregulation in HIV-infected cells. Immunobiol. 184:1992;402-409.
48. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., Baltimore D. HIV-1 Nef protein protects primary cells against killing by cytotoxic T lymphocytes. Nature. 391:1998;397-401.
49. Mangasarian A., Foti M., Aiken C., Chin D., Carpentier J.L., Trono D. The HIV-1 nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity. 6:1997;67-77.
50. Schwartz O., Maréchal V., LeGall S., Lemonnier F., Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature M. 2:1996;338-342.
51. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J.M., Schwartz O. Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity. 8:1998;483-495.
52. Kerkau T., Bacik I., Bennink J.R., Yewdell J.W., Hünig T., Schimpl A., Schubert U. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. M. 185:1997;1295-1305.
53. Cantin R., Fortin J.F., Lamontagne G., Tremblay M. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood. 90:1997;1091-1100.
54. Sperber K., Hamrang G., Louie M.J., Kalb T., Banerjee R., Choi H.S., Paronetto F., Mayer L. Progressive impairment of monocytic function in HIV-1 infected human macrophage hybridomas. AIDS Res. Hum. Retro. 9:1993;657-667.
55. Polyak S., Chen H., Hirsch D., George I., Hershberg R., Sperber K. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J. Immunol. 159:1997;2177-2188.
56. Yoo J., Chen H., Kraus T., Hirsch D., Polyak S., George I., Sperber K. Altered cytokine production and accessory cell function after HIV-1 infection. J. Immunol. 157:1996;1313-1320.
57. Domanico S.Z., Pierce S.K. Virus infection blocks the processing and presentation of exogenous antigen with the major histocompatibility complex II molecules. Eur. J. Immunol. 22:1992;2055-2062.
58. Louie M., Yoo J., Moran T., Mayer L., Sperber K. Impairment of monocytic function after influenza virus infection. Clin Diagn. Lab. Immunol. 2:1995;426-433.
59. Leopardi R., Ilonen J., Mattila L., Salmi A.A. Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes. Cell Immunol. 147:1993;388-396.
60. Ehrlich R. Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation. Immunol. Res. 14:1995;77-97.
61. Thursz M.R., Thomas H.C. Host factors in chronic viral hepatitis. Semin. Liv. Dis. 17:1997;345-350.
62. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375:1995;685-688.
63. Khanna R., Burrows S.R., Argaet V., Moss D.J. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumor cell line. Int. Immunol. 6:1994;639-645.